Feng-Mao An

651 total citations
12 papers, 529 citations indexed

About

Feng-Mao An is a scholar working on Physiology, Molecular Biology and Cancer Research. According to data from OpenAlex, Feng-Mao An has authored 12 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Feng-Mao An's work include Alzheimer's disease research and treatments (7 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (3 papers). Feng-Mao An is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (3 papers). Feng-Mao An collaborates with scholars based in China and Mongolia. Feng-Mao An's co-authors include Guo-Hua Gong, Cheng‐Xi Wei, Ming Bian, Song Chen, Airan Liu, Xiangdong Gao, YU Li-jun, Yu Wang, Wenbing Yao and Guowei Zhang and has published in prestigious journals such as Molecules, Journal of Ethnopharmacology and Oncotarget.

In The Last Decade

Feng-Mao An

12 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng-Mao An China 11 307 232 152 87 74 12 529
Haibing Yu China 8 358 1.2× 267 1.2× 93 0.6× 24 0.3× 26 0.4× 15 570
Oscar Hidalgo‐Lanussa Colombia 14 251 0.8× 37 0.2× 184 1.2× 60 0.7× 84 1.1× 20 617
Nathalie Khoury United States 13 321 1.0× 101 0.4× 105 0.7× 17 0.2× 55 0.7× 28 611
Yanfang Mao China 9 155 0.5× 44 0.2× 166 1.1× 63 0.7× 77 1.0× 14 431
Jiamei Jiang China 13 239 0.8× 39 0.2× 91 0.6× 40 0.5× 43 0.6× 32 556
Jolanta Pupure Latvia 13 225 0.7× 54 0.2× 100 0.7× 18 0.2× 102 1.4× 19 451
Hsin‐Hua Li Taiwan 13 186 0.6× 45 0.2× 235 1.5× 89 1.0× 107 1.4× 26 546
Scott J. Koppel United States 15 398 1.3× 47 0.2× 373 2.5× 57 0.7× 63 0.9× 19 715
Katarzyna Laskowska-Kaszub Poland 10 309 1.0× 154 0.7× 247 1.6× 14 0.2× 32 0.4× 11 608
Jiankang Huang China 13 287 0.9× 137 0.6× 99 0.7× 15 0.2× 41 0.6× 23 542

Countries citing papers authored by Feng-Mao An

Since Specialization
Citations

This map shows the geographic impact of Feng-Mao An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng-Mao An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng-Mao An more than expected).

Fields of papers citing papers by Feng-Mao An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng-Mao An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng-Mao An. The network helps show where Feng-Mao An may publish in the future.

Co-authorship network of co-authors of Feng-Mao An

This figure shows the co-authorship network connecting the top 25 collaborators of Feng-Mao An. A scholar is included among the top collaborators of Feng-Mao An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng-Mao An. Feng-Mao An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
An, Feng-Mao, et al.. (2022). Calycosin ameliorates advanced glycation end product-induced neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease. Chemico-Biological Interactions. 368. 110206–110206. 13 indexed citations
3.
An, Feng-Mao, et al.. (2022). 1,8-Cineole Ameliorates Advanced Glycation End Products-Induced Alzheimer’s Disease-like Pathology In Vitro and In Vivo. Molecules. 27(12). 3913–3913. 22 indexed citations
6.
Dong, Lixia, et al.. (2021). LncRNA NEAT1 promotes Alzheimer's disease by down regulating micro-27a-3p.. American Journal of Translational Research. 13(8). 8885–8896. 39 indexed citations
7.
Gong, Guo-Hua, Feng-Mao An, Yu Wang, et al.. (2018). Comprehensive Circular RNA Profiling Reveals the Regulatory Role of the CircRNA-0067835/miR-155 Pathway in Temporal Lobe Epilepsy. Cellular Physiology and Biochemistry. 51(3). 1399–1409. 53 indexed citations
8.
Gong, Guo-Hua, Feng-Mao An, Yu Wang, et al.. (2018). MiR-153 regulates expression of hypoxia-inducible factor-1α in refractory epilepsy. Oncotarget. 9(9). 8542–8547. 20 indexed citations
9.
Gong, Guo-Hua, Feng-Mao An, Yu Wang, et al.. (2017). miR-15b represses BACE1 expression in sporadic Alzheimer’s disease. Oncotarget. 8(53). 91551–91557. 51 indexed citations
10.
An, Feng-Mao, Guo-Hua Gong, Yu Wang, et al.. (2017). MiR-124 acts as a target for Alzheimer’s disease by regulating BACE1. Oncotarget. 8(69). 114065–114071. 106 indexed citations
12.
Chen, Song, Airan Liu, Feng-Mao An, Wenbing Yao, & Xiangdong Gao. (2011). Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer’s disease by exendin-4. AGE. 34(5). 1211–1224. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026